RiverVest Venture Partners

RiverVest Venture Partners is a prominent venture capital firm specializing in the life sciences sector, focusing on founding and funding early-stage biopharmaceutical and medical device companies across the United States. The firm is dedicated to addressing significant unmet medical needs by developing innovative products that improve patient outcomes. With a strong emphasis on collaboration with entrepreneurs and academic investigators, RiverVest aims to create value for patients, entrepreneurs, and investors through science, strategy, and innovation.

Established in 2000, RiverVest has a proven track record of success, having invested in over 55 companies, with 18 successfully sold and eight going public. Notable exits include Allakos (NASDAQ: ALLK), Mirum Pharmaceuticals (NASDAQ: MIRM), and Spruce Biosciences (NASDAQ: SPRB). The firm's disciplined investment approach and hands-on involvement have led to the development of at least 27 commercial products currently treating patients.

With offices in St. Louis, San Diego, and Cleveland, RiverVest leverages its extensive network and expertise to identify and support promising life science innovations. The firm's commitment to improving patient lives, supporting entrepreneurs, and delivering strong returns to investors underscores its position as a leader in the venture capital industry.